- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.10. | Clinical Laserthermia Systems AB: CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results | 57 | GlobeNewswire (Europe) | Lund, Sweden, October 7th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS") today announces positive results from a clinical safety study on laser ablation, performed using CLS proprietary LITT... ► Artikel lesen | |
| 30.09. | Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B | 1 | Cision News | ||
| CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 04.09. | Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | 1 | Cision News | ||
| 04.09. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | 147 | GlobeNewswire (Europe) | Lund, Sweden - September 4th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for expansion... ► Artikel lesen | |
| 22.08. | Clinical Laserthermia Systems AB: CLS publishes half-year report January - June 2025 | 179 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half year report January - June 2025. Second Quarter Highlights
Record sales revenue of SEK 9,4M... ► Artikel lesen | |
| 27.06. | Clinical Laserthermia Systems AB: Communique from the Annual General Meeting on Friday June 27th in Clinical Laserthermia Systems A | 3 | Cision News | ||
| 06.06. | Clinical Laserthermia Systems publishes annual report for 2024 | 2 | Cision News | ||
| 27.05. | Clinical Laserthermia Systems AB: Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 27, 2025 | 1 | Cision News | ||
| 16.05. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Interim report for January - March 2025 | 186 | GlobeNewswire (Europe) | Summary of the interim report (relates to the Group)Three months (01/01/2025-03/31/2025)
Net sales totaled SEK 4,496,000 (SEK 3,140,000).
Operating profit totaled SEK -7,868,000 (SEK -16,992,000).
Profit/loss... ► Artikel lesen | |
| 28.04. | ClearPoint Neuro, Inc.: ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism to Include 1.5 T MRI | 181 | ACCESS Newswire | SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the... ► Artikel lesen | |
| 28.04. | Clinical Laserthermia Systems, together with its partner ClearPoint Neuro, announces FDA submission to expand the labeling of ClearPoint Prism® to include 1.5 T MRI guidance | 4 | Cision News | ||
| 15.04. | Clinical Laserthermia Systems AB: Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis | 178 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS or the "Company") today announces that updated clinical guidelines with recommendations supporting the use of Laser Interstitial Thermal Therapy (LITT)... ► Artikel lesen | |
| 08.04. | Clinical Laserthermia Systems AB: Proposed U.S. tariffs expected to have minimal impact on CLS business | 160 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") clarifies that the proposed U.S. tariffs are expected to have minimal impact on its total business, including operations... ► Artikel lesen | |
| 21.02. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2024 | 266 | GlobeNewswire (Europe) | Summary of the year-end report (relates to the Group)Full year (01/01/2024-12/31/2024)
Net sales totaled SEK 18,783,000 (SEK 8,273,000).
Operating profit/loss totaled SEK -54,254,000 (SEK -65,933... ► Artikel lesen | |
| 07.02. | Clinical Laserthermia Systems AB: CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request | 1.216 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that Lars-Erik Eriksson, co-founder, long-time board member and former CEO, is leaving the board of directors... ► Artikel lesen | |
| 14.01. | Clinical Laserthermia Systems AB: CLS Recaps 2024 and Provides Outlook for 2025-26 | 559 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that, in its recap of 2024, in the first nine months of 2024 compared to the same period 2023, CLS saw... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 49,000 | +0,06 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Fresenius auf "Buy" mit einem Kursziel von 55 Euro belassen. Einer Experteneinschätzung zufolge müsse das deutsche Krankenhaussystem seine... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 45,860 | -2,88 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec auf "Outperform" mit einem Kursziel von 56,40 Euro belassen. Mit der Reifung des Gesundheitssystems... ► Artikel lesen | |
| DRAEGERWERK | 76,60 | -1,03 % | Drägerwerk Vz: Wochengewinner in KW 42 im TecDAX und SDAX! | ||
| MEDTRONIC | 80,64 | +0,12 % | Medtronic and DASI Simulations Partner to Advance the Future of TAVR Through Predictive Modeling and Personalized Planning | Partnership launches AI solution to enhance predictive heart valve visualization and personalize valve treatment planning decisions enabling the future of TAVR for structural heart patients DUBLIN,... ► Artikel lesen | |
| INTUITIVE SURGICAL | 470,85 | +0,19 % | Märkte am Morgen: TeamViewer, Adidas, Alibaba, Amazon, Netflix, Intuitive Surgical | Die Aktienmärkte stehen vor spannenden Wochen. Immer mehr Unternehmen liefern Quartalszahlen. Das gilt nicht nur für US-Werte. Auch die ersten deutschen Konzerne liefern Ergebnisse. Der DAX hat sich... ► Artikel lesen | |
| THERMO FISHER | 494,00 | +0,36 % | Drei Säulen für starke Renditen: Warum Biotech-Zulieferer jetzt die wahren Gewinner an der Börse sind! | ||
| TELADOC HEALTH | 8,170 | +0,20 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| ROKU | 83,37 | +0,69 % | Roku may have finally fixed the biggest headache in TV streaming - here's how | ||
| HIMS & HERS HEALTH | 42,000 | +0,17 % | HIMS & HERS: Schon wieder aufnehmen? | Die Aktie der US-Vertriebsplattform für bestimmte Medikamente verlor am Freitag 15,8 % und sogar fast 24 % gegenüber dem Zwischenhoch vom Donnerstag. Wesentlicher Auslöser war Donald Trump mit seinem... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,097 | -2,51 % | Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused... ► Artikel lesen | |
| DEXCOM | 61,13 | +1,11 % | DexCom stock price target maintained at $100 by TD Cowen ahead of Q3 results | ||
| ALCON | 65,52 | +0,06 % | STAAR Surgical Company: Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders | Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL)... ► Artikel lesen | |
| RESMED | 224,20 | +0,49 % | Resmed CEO Mick Farrell explains rebrand, 'digital revolution' | ||
| HEALWELL AI | 0,896 | +0,34 % | HEALWELL AI Inc.: HEALWELLs KI-Plattform DARWEN AI präsentiert eines der weltweit ersten Beispiele für den Einsatz von KI zur Generierung von regulierungskonformen Real-World-Daten (RWD) | HEALWELLs KI-Plattform DARWEN AI präsentiert eines der weltweit ersten Beispiele für den Einsatz von KI zur Generierung von
regulierungskonformen Real-World-Daten (RWD), die den Patienten einen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,530 | +0,34 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |
CLINICAL LASERTHERMIA SYSTEMS AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,013 (+2,15 %) liegt der Kurs bei 0,619 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CLINICAL LASERTHERMIA SYSTEMS AB finden Sie auf Wallstreet Online.